BLIS Technologies Limited
BLT.NZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$34.54M
Close$
$-0.01
131.1% downside
Current Fair Value
131.1% downsideOvervalued by 131.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $34.54 Million |
|---|---|
| Enterprise Value | $30.98 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.68 |
| Outstanding Shares | 1,279,301,599 |
Return
| Return on Equity | 11.73% |
|---|---|
| Return on Assets | 10.22% |
| Return on Invested Capital | 8.39% |
Valuation & Multiples
| P/E Ratio | 54 |
|---|---|
| PEG | -97.88 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.13 |
| Enterprise Value to EBIT | 27.78 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BLIS Technologies Limited
43 employees
CEO: Scott Ogilvie Johnson BLIS Technologies Limited, together with its subsidiaries, specializes in creating and distributing health-focused products. These offerings are underpinned by unique bacterial strains that exhibit bacteriocin activity. The company promi...